Lisata Therapeutics Ownership | Who Owns Lisata Therapeutics?

Overview RevenueFinancials Chart Transcripts

Lisata Therapeutics Ownership Summary

Lisata Therapeutics is owned by 5.09% institutional investors, 20.89% insiders, and 74.03% retail investors. Vanguard group is the largest institutional shareholder, holding 3.10% of LSTA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.10% of its assets in Lisata Therapeutics shares.

LSTA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Lisata Therapeutics	5.09%	20.89%	74.03%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	270.91K	3.10%	$503.89K
Renaissance	131.72K	1.52%	$659.89K
Deltec asset management	90.00K	1.04%	$450.90K
Rangeley capital	75.00K	0.86%	$375.75K
Geode capital management	70.89K	0.82%	$355.21K
Css llc/il	61.90K	0.71%	$310.11K
Blackrock funding, inc. /de	54.86K	0.63%	$274.83K
Penderfund capital management	47.50K	0.55%	$237.97K
Virtu financial	42.21K	0.49%	$211.00K
Vanguard fiduciary trust	34.92K	0.40%	$174.93K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Rangeley capital	75.00K	0.37%	$375.75K
Deltec asset management	90.00K	0.08%	$450.90K
Penderfund capital management	47.50K	0.04%	$237.97K
Css llc/il	61.90K	0.01%	$310.11K
Sol capital management	12.18K	0.01%	$29.34K
Jbf capital	13.23K	0.01%	$66.30K
Virtu financial	42.21K	0.01%	$211.00K
Gts securities	31.40K	0.01%	$157.29K
Connective capital management	1.02K	0.00%	$5.09K
Founders capital management	1.67K	0.00%	$8.35K

Top Buyers

Holder	Shares	% Assets	Change
Deltec asset management	90.00K	0.08%	90.00K
Rangeley capital	75.00K	0.37%	75.00K
Css llc/il	61.90K	0.01%	61.90K
Penderfund capital management	47.50K	0.04%	47.50K
Virtu financial	42.21K	0.01%	42.21K

Top Sellers

Holder	Shares	% Assets	Change
Bml capital management	-	-	-73.35K
Ground swell capital	-	-	-38.99K
Dimensional fund advisors lp	-	-	-14.25K
Tower research capital llc (trc)	785.00	0.00%	-1.77K
Jpmorgan chase	-	-	-13.00

New Positions

Holder	Shares	% Assets	Change	Value
Deltec asset management	90.00K	0.08%	90.00K	$450.90K
Rangeley capital	75.00K	0.37%	75.00K	$375.75K
Css llc/il	61.90K	0.01%	61.90K	$310.11K
Penderfund capital management	47.50K	0.04%	47.50K	$237.97K
Virtu financial	42.21K	0.01%	42.21K	$211.00K

Sold Out

Holder	Change
Wells fargo & company/mn	-1.00
Loring wolcott & coolidge fiduciary advisors llp/ma	-2.00
Barclays	-4.00
Raymond james financial	-6.00
Jpmorgan chase	-13.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	14	-44.00%	441,823	-38.21%	5	7.59%	8	-38.46%	-	-100.00%
Dec 31, 2025	18	-18.18%	684,695	-9.09%	7	10.23%	8	-20.00%	6	50.00%
Sep 30, 2025	21	5.00%	752,137	-3.88%	8	10.57%	9	12.50%	4	33.33%
Jun 30, 2025	20	-9.09%	782,490	-0.11%	9	10.96%	8	-20.00%	3	-40.00%
Mar 31, 2025	22	15.79%	783,376	-0.29%	9	10.23%	10	66.67%	5	150.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	191.37K	2.10%	-
Vanguard Institutional Extnd Mkt Idx Tr	80.44K	0.88%	-
Fidelity Extended Market Index	39.15K	0.43%	-2.07K
Pender Alternative Arbitrage Plus F	27.00K	0.30%	-13.50K
Fidelity Series Total Market Index	10.37K	0.11%	1.14K
Spartan Extended Market Index Pool F	10.30K	0.11%	3.54K
NT Ext Equity Mkt Idx Fd - L	7.14K	0.08%	-
Northern Trust Extended Eq Market Idx	7.14K	0.08%	-
NT Ext Equity Mkt Index Fund - Lending	7.14K	0.08%	-
Spartan Total Market Index Pool G	4.64K	0.05%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 08, 2021	MYERS STEVEN S	-	Buy	$30.19K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q3	-	-

LSTA Ownership FAQ

Who Owns Lisata Therapeutics?

Lisata Therapeutics shareholders are primarily institutional investors at 5.09%, followed by 20.89% insiders and 74.02% retail investors. The average institutional ownership in Lisata Therapeutics's industry, Biotech Stocks , is 35.75%, which Lisata Therapeutics falls below.

Who owns the most shares of Lisata Therapeutics?

Lisata Therapeutics’s largest shareholders are Vanguard group (270.91K shares, 3.10%), Renaissance (131.72K shares, 1.52%), and Deltec asset management (90K shares, 1.04%). Together, they hold 5.65% of Lisata Therapeutics’s total shares outstanding.

Does Blackrock own Lisata Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Lisata Therapeutics.

Who is Lisata Therapeutics’s biggest shareholder by percentage of total assets invested?

Rangeley capital is Lisata Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.37% of its assets in 75K Lisata Therapeutics shares, valued at 375.75K$.

Who is the top mutual fund holder of Lisata Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Lisata Therapeutics shares, with 2.10% of its total shares outstanding invested in 191.37K Lisata Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools